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Abstract
Background: Extravillous trophoblast (EVT) cells are of pivotal importance in human embryo implantation and
homeostasis of the maternal fetal interface. Invasion of the endometrium by EVT contributes to placental
anchorage, spiral artery remodeling, immunological defense, tolerogenic responses, and several collaborative cross
talks involved in establishing and maintaining a successful pregnancy. We report here an improved protocol for the
isolation of fully differentiated EVT cells from the basal plate of the human term placenta.
Methods: The basal plate was carefully dissected from the villous tissue and the amniochorion membrane prior to
enzymatic digestion. Term basal EVT cells were isolated using a 30 and 60% Percoll gradient. A panel of markers
and characteristics of the isolated cells were used to confirm the specificity and efficiency of the method so that
their potential as an investigative tool for placental research could be ascertained.
Results: Isolated cells were immunoreactive for cytokeratin-7 (CK-7), placental growth factor, placental alkaline
phosphatase, human leukocyte antigen G1 (HLA-G1), and α1 and α5 integrins, similarly to the EVT markers from
first trimester placental villi. Around 95% of the isolated cells labeled positively for CK-7 and 82% for HLA-G1. No
significant change in viability was observed during 48 h of EVT culture as indicated by propidium iodide incorporation
and trypan blue test exclusion. Genes for metalloproteinases MMP-2 and MMP9 (positive regulators of trophoblast
invasiveness) were expressed up to 48 h of culturing, as also the gelatinolytic activity of the isolated cells. Transforming
growth factor (TGF)-beta, which inhibits proliferation, migration, and invasiveness of first-trimester EVT cells, also
reduced invasion of isolated term EVT cells in transwell assays, whereas epidermal growth factor was a positive
modulator.
Conclusions: Term basal plate may be a viable source of functional EVT cells that is an alternative to villous
explant-derived EVT cells and cell lines. Isolated term EVT cells may be particularly useful in investigation of the role
of trophoblast cells in pathological gestations, in which the precise regulation and interactive ability of extravillous
trophoblast has been impaired.
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Background
The placenta is a highly specialized essential organ that
includes the chorionic villous tree and decidua. The villi
are formed by the syncytiotrophoblast (ST) layer in
contact with maternal blood, and the cytotrophoblast
(VCT) layer, the source of proliferative cells that gives
rise to the ST and the extravillous cytotrophoblast (EVT)
from the tips of the villi [1]. EVT differentiate in cell
subpopulations, characteristically invasive, forming the
trophoblastic shell and, interstitial and endovascular
cells, respectively invading the decidua and myometrium
and uterine vessels [2]. Invasive behavior of these cells is
particularly prominent at the first-trimester, although
transient, accurately regulated and spatially confined to
the endometrium and part of the myometrium [2].
The biological events involved in trophoblast invasion
have been compared to those of neoplastic cells [3],
making the mechanisms of the former’s invasiveness of
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great common interest. A high incidence of invasive-
ness-related changes in trophoblast in adverse pregnancy
outcomes, such as placenta accreta, pre-eclampsia [4]
and other gestational diseases also highlights the impor-
tance of studying EVT cells [5].
First and second trimester human EVT cells constitute
a prominent cell population with highly migratory/inva-
sive activities [2]. At term, the cells are partially replaced
by fibrinoid and therefore become less numerous. This
cell population derives from the small spindle-shaped
diploid cells found in the initial gestational trimester
[6,7], having a non-proliferative profile, tendency towards
polygonal column formation with polyploidy, and reduced
invasive activity [8]. These characteristics have been con-
sidered disadvantageous for using term basal plate EVT
cells. Use of first and second trimester pregnancy tissues,
however, depends on ethical considerations and legal
regulations, which differ among countries. Hence, term
placentas offer an alternative and more readily available
source for EVT preparations. Cultured EVT cells also
share common phenotypic characteristics in spite of the
different protocols described for the isolation first, second
and third trimester cells [9-19]. EVT also play key roles in
maternal immunoregulation and the molecular regulatory
dialogue at the maternal fetal interface. Absence or
unregulated production of regulatory factors has been
reported in placental-associated gestational pathologies
[4,5,8]. In this context, the study of cytotrophoblast cells
directly from these microenvironments would allow the
analysis of a multitude of impaired signaling pathways,
bringing new ways of interpreting the causes and conse-
quences of these pathological conditions.
Villous tissue, villous explant outgrowth, and amnio-
chorion membrane are useful sources from which
trophoblast cells can be isolated [9-19]. Explant cultures
of anchoring villi and VCT/EVT cells isolated from
villous tissue obtained from first-trimester placentas
have also been used successfully to yield migratory,
temporarily proliferative cytotrophoblast cells for diffe-
rentiation and invasion studies [9,12]. The contribution
of these procedures to elucidating the physiology and
paracrine regulation of trophoblast cells is inestimable
[20-23]. Third trimester explants and villous digestion
have also been used to yield VCT cells [15,16], although
they produced fewer viable and invasive VCT/EVT cells
than first trimester explants. Terminally differentiation
of third trimester VCT cells in vivo is considered an
experimental obstacle [11,24].
Term EVT cells can also be isolated in large quantities
from the amniochorion membrane [15,17]. These cells
tend to merge in vitro, resulting in giant polyploid
multinucleated trophoblast cells [17], which are phe-
notypically and functionally different from in vivo EVT
cells in respect of invasive and interactive behavior. The
transformation of mononuclear EVT cells into giant mul-
tinucleated trophoblast cells and polyploidization seem to
be mechanisms associated with villous trophoblast diffe-
rentiation [24], but not with the multiple particular fea-
tures of the in vivo extravillous cytotrophoblast inhabiting
the decidua. EVTs from decidual basal plate are also in
direct contact to maternal cells, which may be important
in getting a better understanding of the invasive and tole-
rance process promoted by these cells.
Thus, we investigated whether the basal plate from
term placenta might be a viable source of fully differen-
tiated EVT cells that can be used as a model of tropho-
blast biology in healthy and pathological conditions.
Methods
Reagents
Collagenase type II, insulin, calcium lactate, sodium pyru-
vate, nucleosides, Trypan blue and fish skin gelatin (Sigma
Chemical Co., St. Louis, USA). Antibiotics, 4′,6′-diamino-
2-phenylindole dihydrochloride (DAPI), deoxynuclease
(DNAse) type I, Dulbecco’s Modified Eagle Medium:
Nutrient Mixture F-12 (DMEM/F12), fetal bovine serum
(FBS), fibronectin, Iscove’s Modified Dulbecco’s Medium
(IMDM), Tryzol® reagent, SuperScript® First Strand kit, and
Taq Polymerase (Invitrogen Carlsbad, USA). Matrigel,
transwell inserts and filters (Becton Dickinson, Franklin
Lakes, USA). Other reagents were from Merck, Darmstadt,
Germany) unless otherwise indicated. The specificities and
sources of antibodies are listed in Table 1.
Tissue collection
Twenty term placentas (37-40 weeks) were obtained from
women having elective Caesarean section with healthy
babies with no pregnancy complications. Ethical commit-
tee approval for this study was granted by the University
Hospital and the Institute of Biomedical Sciences
from University of Sao Paulo, and informed consent
was obtained before surgery. Pools of first trimester
placentas (6-12 weeks) were obtained from legal abortions
of uncomplicated pregnancies. The use of these tissues
was approved by the ethical committee of the Medical
University of Vienna.
Isolation of EVT cells
The term basal plate is a 3-6 mm thick membrane
(Figure 1A-B), which was carefully dissected from the
villous tissue and the amniochorion membrane. Isolation
of EVT cells was adapted from a previously described
procedure for amniochorion cytotrophoblast isolation
[15,25]. Briefly, the fragments were coarsely minced
and ~5 g of wet tissue were incubated for 1 h with
20 mL of DMEM/F12 containing 4% bovine serum albu-
min (BSA), collagenase type II (125 U/mL) and DNase
type I (25 U/mL), at 37°C in a water bath, followed by
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inactivation with 20% FBS. Cell suspension was double-
filtered through a 100 μm mesh followed by a 70 μm
mesh. The suspension was centrifuged at 400×g and the
cells washed and resuspended in complete DMEM/F12
(supplemented with 1% antibiotics, 10% FBS, 0.01% insu-
lin, 520 μg/mL calcium lactate, 56 μg/mL sodium pyruvate
and 1% nucleosides). EVT cells were isolated using a
gradient of 30 and 60% Percoll (GE Healthcare, Uppsala,
Sweden) followed by centrifugation at 700×g for 30 min
[25]. EVTcells were collected from the top of the 30% gra-
dient. When needed, the cell suspension was incubated
with 0.83% ammonium chloride in PBS and centrifuged at
400×g for 5 min for blood cell removal.
For some comparative analyses, first trimester EVT
were also isolated from pooled villous tissue. The pro-
cedure followed steps previously described [26], using
Table 1 List of antibodies
Antibody Isotype Dilution Source
Mouse monoclonal anti-human CK-7 IgG1 1:100 Dako Norden A/S (Glostrup, Denmark)
Mouse monoclonal anti-human HLA-G1 IgG1 1:100 Exbio (Prague, Czech Republic)
Mouse monoclonal anti-human Vm IgG2a 1:50 Dako Norden A/S (Glostrup, Denmark)
Rabbit polyclonal anti-hunan PlAP IgG1 Ready to use Invitrogen (Carlsbad, CA, USA)
Rabbit polyclonal anti-human PlGF IgG1 1:100 Abcam (Cambridge, UK)
Rabbit polyclonal anti-human α1 integrin IgG1 1:100 Millipore (Billerica, MA, USA)
Mouse monoclonal anti-human α5 integrin IgG1 1:50 Abcam (Cambridge, UK)
Mouse monoclonal anti-human desmoplakin I/II IgG1 1:200 Abcam (Cambridge, UK)
Mouse monoclonal anti-human CD68 IgG1 1:50 Dako Norden A/S (Glostrup, Denmark)
Rabbit polyclonal anti-human α6 integrin IgG1 1:100 Abcam (Cambridge, UK)
FITC labeled rabbit anti-mouse IgG IgG1 1:20 Dako Norden A/S (Glostrup, Denmark)
TRITC labeled goat anti-rabbit IgG IgG1 1:50 Sigma Chemical Co (St. Louis, MO, USA)
AlexaFluor 488 labeled rabbit anti-mouse IgG IgG1 1:1000 Molecular Probes (Eugene, OR, USA)
AlexaFluor 568 labeled goat anti-rabbit IgG IgG1 1:1000 Molecular Probes (Eugene, OR, USA)
Zenon® Alexa Fluor 488 anti-mouse IgG1 See supplier’s instruction Invitrogen (Carlsbad, CA, USA)
Zenon® R-phycoerythrin anti-mouse IgG1 See supplier’s instruction Invitrogen (Carlsbad, CA, USA)
Figure 1 The term decidual basal plate. (A) Panoramic view (25x) showing the basal plate (BP), chorionic villi (ChV) and the chorionic plate
(ChP) of the human placenta. Dotted line indicates the area initially dissected for isolation of EVT cells. (B) High magnification (100x) of the square
highlighted in Figure A, in which are indicated extravillous cytotrophoblast cells (EVT), decidual cells (DC) and leukocytes (LK) at the basal plate
(BP). (fb) fibrinoid. (ChV) chorionic villi. Hematoxylin-eosin staining.
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adapted enzymatic dispersion and Percoll density gra-
dient centrifugation (GE Healthcare).
Cell culture
The isolated cells were plated on culture dish plates
(Corning Incorporated, Corning, NY, USA) coated with
Matrigel (1:1 in DMEM/F12) or fibronectin (10 μg/mL
in PBS). Plated cells were incubated for 12h at 37°C
under a humidified atmosphere of 5% CO2 in air for cell
attachment. Non-adherent cells were washed out, and
complete DMEM/F12 or IMDM supplemented with 10%
FBS was added.
Immunofluorescence
Isolated cells (3×105 cells/well) plated out for 48 h were
fixed in ice-cold methanol. For blocking, 0.05% fish skin
gelatin in PBS was used and cells were incubated with
primary antibody followed by incubation with fluo-
rescent secondary antibody or incubated with Zenon®
Tricolor mouse IgG labeling kit (Table 1). Nuclei were
stained with 0.2 μM DAPI. The coverslips were mounted
with 1:9 (v/v) PBS/glycerol. Fluorescent cells were quan-
tified as the percentage of reactive cells in the total
number of stained nuclei per microscopic field, in a total
of 4 fields per sample, with at least 3 samples used on
different occasions. Negative controls were developed by
adding un-related antibodies.
Flow cytometry
For cell viability assays, cells (3×105 cells/well) were
labeled with 2 μg/mL propidium iodide (PI) and analyzed
by FACS Canto® flow cytometry (Becton Dickinson). For
intracellular labeling, cells (3×105 cells/well) were incu-
bated in 5% normal goat serum (Vector Laboratories,
Burlingame, USA), washed, fixed and permeabilized using
commercial buffers (e-Bioscience, San Diego, USA). The
cells were incubated in permeabilization buffer with target
antibody previously conjugated with a Zenon® Tricolor
mouse IgG labeling kit. They were finally resuspended in
0.1% BSA in PBS and analyzed, the data being handled by
FlowJo® software (Tree Star Inc., Ashland, USA).
Trypan blue dye exclusion test
Isolated cells (2.5×104 cells/well) were mixed with
0.4% trypan blue dye in the ratio 1:1 (v/v), and the
numbers of viable and dead cells were counted using
a hemocytometer.
RNA extraction and RT–PCR
Total RNA was extracted (3×105 cells/well) using Tryzol.
The RNA was assessed by ultraviolet spectrophotometry
using a ND-100 spectrophotometer (Nano Drop Tech-
nologies, Rockland, USA), and the cDNA was synthesized
from 1 μg of total RNA using a SuperScript® First Strand
kit. RT–PCR involved Taq polymerase. The primer se-
quences, annealing temperatures, and PCR product sizes
are shown in Table 2. Thermal cycling conditions were
98°C for 2 min, 94°C for 45 sec, 56°C, 60°C, 60°C or 54 for
45 sec, and 72°C for 40 sec, followed by a final extension
at 72°C for 5 min. PCR products were visualized with ethi-
dium bromide after electrophoresis on 1% agarose gel.
The band densitometric analyses were performed with
Image J software (National Institute of Health, Bethesda,
Maryland, USA).
Invasion assay
Invasion was assayed in transwell inserts using 24-well fit-
ted inserts with 8 μm pore size. The inserts were precoated
with 15 μL Matrigel (1:1v/v in DMEM/F12) or 30 μL
fibronectin (10 μg/mL in PBS). Cells (5.6×104 cells/well)
were resuspended in complete DMEM/F12, treated with
10 ng/mLTGF-β or 50 ng/mL EGF, and seeded. The lower
chambers were loaded with complete DMEM/F12. Non-
invading cells were removed after 48 h, and the mem-
branes fixed and stained with 0.2% violet crystal dye.
DNA incorporation by BrDUr
Cells plated at 3×105 cells/well and cultured for 24 and
48 h were used to assess proliferation rates. Cultured
cells were incubated with 1.5 μg/mL 5-bromo-2′-deox-
yuridine (Merck, Darmstadt, Germany) in DMEM/F12
complete medium for 3 h before fixation in 4% parafor-
maldehyde in PBS for 20 min at room temperature.
Table 2 Sequence of primers used in this study
Gene Sequence Number of cycles Annealing (°C) Size
18S Forward: 5′ GTAACCCGTTGAACCCCATT3′ 20 56 115 bp
Reverse: 5′ CCATCCAATCGGTAGCG 3′
GADPH Forward: 5′CTGTTGCTGTAGCCAAATTCGT3′ 28 60 102 bp
Reverser: 5′ACCCACTCCTCCACCTTTGA3′
MMP-2 Forward: 5 AGCTCCCGGAAAAGATTGATG3′ 35 60 101 bp
Reverse: 5′ CAGGGTGCTGGCTGAGTAGAT3′
MMP-9 Forward: 5′ GAGGTGGACCGGATGTTCC 3′ 35 54 106 bp
Reverse: 5′ AACTCACGCGCCAGTAGAAG 3′
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BrDU was used to detect cells incorporating DNA, using
a mouse IgG antibody against BrDU.
Gelatin zymography
The presence of proteases in the culture supernatants was
detected by gelatin zymography. The harvested media
were standardized according to the protein content of the
cell lysates. Thirty μg total proteins were separated on
10% SDS-PAGE gels containing 5 mg/mL gelatin. The gels
were washed in 2.5% Triton X-100 at 37°C and incubated
overnight at 37°C in reaction buffer (0.05M Tris-HCl,
pH=8.5, 10 mM CaCl2, 1 μM ZnCl2). The gels were stained
with Coomassie solution (0.5% Coomassie brilliant blue
R-250 in 10% methanol and 10% acetic acid) and de-
stained in 10% methanol and 10% acetic acid. Clear zones
of gelatin lysis against the blue background stain indicated
the presence of gelatinolytic activity. The lysis zones from
each sample lane were analyzed using Image J software
(National Institute of Health, Bethesda, Maryland, USA).
Photographic documentation
An Axiovert S100 inverted light microscope (Zeiss,
Jena, Germany) was used for general cell morphology
and cell counting. Immunofluorescence was analyzed using
an Axioskop 2 fluorescence microscope (Zeiss) and the im-
ages were taken with the program AxioVision 4.7 (Zeiss).
Statistical analysis
Statistical analyses were based on one-way analysis of
variance followed by a Student-Newman-Keuls multiple
comparisons test using Prism v5.0 software from GraphPad
(San Diego, CA, USA).
Results
Characterization and purity of term basal plate EVT
The yield of isolated cells from the basal plate of term pla-
centa was generally around 2-6×106 cells/20 g tissue. After
isolation, cells were homogenous, small and roundish in
morphology with large nuclei and prominent nucleoli
(Figure 2A). The isolated cells were not multinucleated or
giant cells. Subsequently, the cells organized into columns
(Figure 2B-C) and most showed enlarged polygonal cyto-
plasm and cell protrusions (Figure 2D-E), suggesting a
migratory phenotype.
The isolated cells have not stained for vimentin (Vm),
but reacted positively to cytokeratin (CK)-7 (Figure 3B-C).
Cultures of endometrial stromal cells positive to anti-
vimentin were used as positive control (Figure 3B –
insert). Most were also positive for placental growth
factor (PlGF) and placental alkaline phosphatase (PlAP)
(Figure 3E-F). Moreover, the great majority of these
cells were negative for CD68 (Figure 3G), α6 integrin
(Figure 3H) and desmoplakin I/II (Figure 3I). By flow
cytometry, an average of 95% of these cells were CK-
7 positive, negative for Vm and 82% positive for human
leukocyte antigen G1(HLA-G1), corroborating the immu-
nofluorescence findings (Figure 4A-D).
Figure 2 General morphology of isolated and cultured term
basal plate cells. (A) After isolation (200x). (B) Cells organized in
cell columns after 24 h of culture on Matrigel (200x). (C) Higher
magnification of B (400x). (D-F) After 48 h of culture, cells exhibit
projections indicating migratory activity (1000x). (A) Phase-contrast.
(B-F) Mayer’s hematoxylin staining.
Borbely et al. Reproductive Biology and Endocrinology 2014, 12:7 Page 5 of 12
http://www.rbej.com/content/12/1/7
First trimester EVT cells contain a specific repertoire
of adhesion molecules, closely related to the invasive
process, and special antigens from the histocompatibility
complex. The persistence of these characteristics in 48 h-
cultured term EVT population was also assessed and
compared by immunofluorescence for HLA-G1 HLA-G1
(Figure 5B-C), 1 integrin (Figure 5E-F) and 5 integrin
(Figure 5H-I). The percentages of HLA-G1 were quite
similar between both groups, although first trimester
EVT presented higher percentages of both 1 and 5 integ-
rin expression (summarized in Table 3).
Cultured term basal plate EVTs are viable and preserve
mRNA expression
Cell viability was assessed by PI incorporation and the
trypan blue exclusion method at 24 and 48 h of cultur-
ing using different culture media with varying compos-
ition. Compared to DMEM/F12, IMDM medium has
additional amino acids, vitamins and inorganic salts, be-
sides HEPES and selenium, which could be an advantage
to improve cell proliferation and viability. The two
different types of medium used during cell culturing, how-
ever, have no effects on cell viability (Figure 6A-B)
and proliferation. Proliferation assessed by BrDU showed
that EVT cells were indeed not proliferating, as expected
for terminal differentiated EVT cells (data not shown).
Gene expression in term EVT cell was preserved during
the culture time, as indicated by GADPH and 18S gene
expression (Figure 6C).
Metalloproteinase expression and gelatinolytic activity
MMP-2 and MMP-9 mRNA expression was investigated
as key molecules to cell invasion. MMP-2 mRNA was
expressed at all times of culture (Figure 6C-D). In con-
trast, expression of MMP-9 mRNA was low expressed
after isolation, but it increased at 24 h and thereafter
(Figure 6C-D). Proteolytic activity of cultured cells was
also measured in the culture supernatants using gelatin
zymography; gelatinolytic activity was seen when EVT
cells were cultured on Matrigel (Figure 7C). This activity
increased in the presence of EGF and decreased in the
presence of TGF-β relative to the control (Figure 7D).
The effects of EGF and TGF-β were not so evident in
the presence of fibronectin.
Term basal plate EVT maintains their invasive properties
The invasion potential of EVT cells was evaluated by
transwell inserts coated with Matrigel and fibronectin in
Figure 3 Representative immunofluorescence characterization and purity of isolated term basal plate cells cultured for 48 h. (A, D)
Negative controls of immunostaining. (B) Vimentin staining (200x); insert shows vimentin-expressing endometrial stromal cells (200x). (C) CK-7
staining (200x); insert shows a CK-7 positive cell exhibiting projections (1000x). (E) PlGF staining (400x). (F) PlAP staining (200x). (G) CD68 staining
(200x). (H) Alpha6-integrin staining (200x). (I) Desmoplakin I/II staining (200x).
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the presence of TGF-β and EGF at concentration of 10
and 50 ng/mL, respectively. TGF-β decreased invasion,
whereas EGF led to a significant enhancement of inva-
sive activity (Figure 7A-B). No changes in proliferation
rates were seen after TGF-β and EGF addition to the
culture system (data not shown).
Discussion
We have shown that term basal plate can be a source of
viable and functional EVT cells. Isolated EVT cells were
positive for CK-7, PlAP, PlGF, HLA-G, and α1 and α5
integrins, the latest three markers also found in first
trimester EVT. The viability of these cells and gene tran-
scription along the culture times indicate the suitability
of the methods for EVT maintenance. In addition, term
EVT cells also respond differentially to regulatory mole-
cules that inhibit or stimulate cell invasion, expressing
MMP-2 and MMP-9 as well as showing gelatinolytic
activity.
In this study we established a standardized procedure
that was successfully applied to the isolation of EVT cells
from term placentas. This protocol adapted the enzym-
atic cell dissociation, by using an enzymatic cocktail
instead of trypsin digestion. This procedure resulted in
high number of isolated and viable cells, from which
EVT cells were subsequently selected by Percoll.
In contrast to villous and amniochorion membrane
EVT-derived cells [15,25], EVT cells are exposed to the
surrounding microenvironment of extracellular matrix
components, which in turn play vital roles in the func-
tions of these cells [26-28]. An important factor for cell
viability may therefore be linked to the availability and/
or activity of certain proteins of the ECM, whose activity
is mediated by cadherins, integrin-matrix ligand among
others. The ability of the collagenase in dissociating
EVT cells by only cleaving the peptide bonds in the
triple helical collagen molecules [29,30], and therefore
preserving surface cell molecules and receptors may be a
differential crucial factor in our protocol.
Culturing EVT cells in different culture media could
provide a myriad of beneficial results. Therefore, the
effect of two culture media on the cell viability of these
Figure 4 Representative flow cytometry characterization and purity of isolated term basal plate cells cultured for 48 h. Flow cytometry
plots show cell size and cytoplasmic granularity (A), the amount of CK-7 positive cells (B), the amount of vimentin positive cells (C) and HLA-G1
positive cells (D). The data are representative of three independent assays.
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cells was also tested. DMEM/F12 provided acceptable
cell viability rates when appropriately supplemented and
similar to IMDM, when added of only insulin, SBF and
antibiotics. Thus, culturing cells with any of these media
makes the cells grow healthy, maintains their cell char-
acteristics and keeps them differentiated and viable,
although none induced proliferation.
EVT cells are the only cell type expressing cytoke-
ratin filaments in the term basal plate, when glands
and uterine epithelium are no longer present [31,32].
Thus, the expression of CK-7 and the rare or absence
of vimentin and CD68 reactive cells respectively iden-
tifying mesenchyme and macrophage cell lineages, as
observed herein, confirm the trophoblastic nature of
Figure 5 Term basal plate EVT cells express the main EVT markers similarly to first trimester EVT cells cultured on fibronectin for 48 h.
(A,D,G) Negative controls of the immunofluorescence reactions (200x). (B-C) HLA-G staining (200x). (E-F) Alpha1-integrin staining (200x). (H-I)
Alpha5-integrin staining (200x).
Table 3 Quantitative analysis of 48 h cultured EVT-markers
CK-7 (%) HLA-G (%) α1- integrin (%) α5- integrin (%)
Term Basal plate EVT 95±3 72±7 52±9 53±16
First trimester villous EVT 94±5 71±9 64±3 78±7
A total amount of 200 DAP-I positive cells were counted from four randomly microscopic fields on 200x magnification/slide (n=3 slides). At the same microscopic
fields using appropriated filters, double-positivity cells for CK-7 and, HLA-G1, alpha1-integrin or alpha5 integrin was also counted. The values were expressed as a
percentage of the total DAP-I positive cells (According to Pollheimer et al., [26]).
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the isolated cells and the high degree of purity of the
cell cultures.
Several other markers were also investigated in this
study and provided further evidence of the purity of the
EVT cell population. The isolated EVT cells expressed
PlGF, a key placental angiogenic factor [15,16,18], which
was consistent with previous studies showing upregulation
of this growth factor by term extravillous trophoblast pop-
ulations [33,34]. These cells were also reactive to the anti-
body anti-PlAP, a glycosylphosphatidylinositol-trophoblast
anchored protein located on the apical membrane of the
syncytiotrophoblast and in EVT cells in the term placental
bed, notably in the interstitial cytotrophoblast within the
maternal decidua [18,35]. The absence of villi cytotropho-
blast and syncytiotrophoblast in our cell preparations were
also suggested by the absence of desmoplakin I/II staining,
peculiar to these trophoblast cell types [36].
Among all trophoblast markers, HLA-G1 is of special
functional and immune importance. It is considered a
tolerogenic molecule responsible for the reprogramming
of local maternal immune response [37]. HLA-G1 is
highly expressed by both endovascular and interstitial
EVT [38,39] and increases during trophoblast migration
towards the spiral arteries [40] - ref-29. Consistent with
the others EVT markers and similar to EVT isolated
from early placentas, the isolated term basal plate EVT
cells were also reactive to HLA-G1.
EVT cells isolated from term basal plate also seem to
preserve their invasive phenotype through the positive
expression of α1 and α5 integrins, and the negative
expression of α6 integrin, as expressed by first trimester
EVT cells [41-44]. These extracellular matrix receptors
play a pivotal role in stabilizing EVT cell columns by
binding to fibronectin and promoting invasiveness upon
interaction with collagens and laminin [41-44].
During the first 48 h, cultured EVT cells show a num-
ber of characteristics indicating viable and fully active
cells, although without proliferative activity. Limited
proliferative capacity, commonly found in fully differen-
tiated cells, apparently does not interfere for the short
periods with the biological properties of EVT cells.
Prolonged EVT cell culturing, as for many other differ-
entiated cells, results in gradually decreasing viability,
suggesting low adaptability to the culture conditions or
Figure 6 Cell viability and mRNA expression of term basal plate
EVT cells at different times of culture. Cell viability was analyzed
by PI incorporation and trypan blue exclusion using complete
DMEM/F12 (A) and supplemented IMDM (B). The data represent the
mean±SEM of four independent assays. (C) Agarose gel electrophoresis
of amplified PCR products of GAPDH, 18S, MMP-2 and MMP-9 genes.
(D) Representation of the RT-PCR data as determined by densitometric
analysis of gel bands expressed as a ratio of GAPDH expression. The
data represent the means±SEM from three independent experiments.
**p<0.01; ***p<0.001 versus control.
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the absence of maintenance specific factors from the
maternal-fetal interface [17].
Activation of MMPs is required for first trimester EVT
invasion [24]. We have also shown term basal plate EVT
cells express MMP-2 and MMP-9 mRNA, and active
gelatinolytic secretion, showing that term EVTs have
potential to invade. As in other EVT invasive models
[21,45], term EVT are also modulated by TGF-β and
EGF, in which EGF increases and TGF-β decreases
invasion. These data reinforce the term basal plate EVT
potential for invasion. Although in situ the invasive
EVT activity at term is considered down regulated/sup-
pressed, clearly the culture conditions could change this
phenotype. As expected, culture conditions did not re-
produce the plethora of regulatory molecules, ECM
components, hormones and other factors that constitute
the placental microenvironment. These data, however,
emphasize the plasticity of term EVT cells in response to
different stimuli and conditions, making them suitable for
experimental purposes.
Different EVT models, regardless of their sources, can
provide cells of quality and specificity for a number of
experimental analyses. The value of VCT cells derived
from first/second trimester villi for invasion studies is
irrefutable; these cells develop invasive abilities in vitro,
although in vivo some of them may never interact dir-
ectly with the endometrial tissue, remaining as floating
villi. Term basal plate EVT, on the other hand, beside
functionally active in invasion, is fully differentiated, has
already invaded maternal tissues, and has been in con-
tact with ECM, maternal immune and non-immune cells
throughout gestation. In this regard, these cells are excel-
lent candidate for studies concerning the interrelationship
between maternal immune, vascular and decidual systems,
and trophoblast. EVT cells isolated from term basal plate
also have the advantage of not fusing to form syncytia or
multinucleated cells, as seen in amniochorion EVT [8,15].
Although EVT cells are abundant and easily isolated in
first trimester placenta, it is not always possible to deter-
mine whether they come from a healthy gestation, as the
interval between the functional unbalance and the first
signs of one disease can be of several weeks. Given that,
whether samples from the first trimester were committed
to some further gestational pathology remains unknown.
Conclusions
An adapted method for isolating fully differentiated term
basal plate EVT has been presented, which may provide a
reliable in vitro model for advancing our understanding of
a number of processes regulating trophoblast biology.
Accordingly, term EVT cells can support future studies on
the differences between first and third trimester phy-
siology, and most importantly, comparisons with third
trimester pathological gestations, even those associated
Figure 7 Term EVT cells maintain their capacity to invade.
TGF-β and EGF modulate the invasion of basal plate EVT maintained
in (A) Matrigel or (B) fibronectin coated transwell inserts and
cultured for 48 h. *p<0.05; **p<0.01; ***p<0.001 versus control. (C)
MMP-2 and MMP-9 activities in the presence of TGF-β and EGF in
basal plate EVT cultured for 48 h on Matrigel. (D) Results of densitometric
analysis of gel electrophoresis expressed as fold change in relation
to control cultures. In panels A, B and D the data represent the
means±SEM of three independent experiments.
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with EVT-invasion deficiencies. Finally, this would cir-
cumvent ethical problems regarding the use of first
trimester placenta in countries where abortion is not
allowed.
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